The Global Cancer Drug Development Workshop was put on in September 2022 by the Accelerating Anticancer Agent Development & Validation (AAADV), American Association of Clinical Oncology (ASCO), and Cancer Drug Development Forum (CDDF).
The three-day virtual workshop reached a global audience and featured training and education around pediatric and rare cancers and serving populations who lack access to new medicine for common diseases due to socioeconomic status.
Led by the vision, commitment, and dedication of H. Kim Lyerly, M.D., B.S., F.A.C.S, F.S.S.O. at Duke University School of Medicine, the virtual workshop enabled this vital training, education, and promotion of policies for developing new therapeutics to be available to more than elite institutions in major cities.
The workshop was hosted on Blue Sky eLearn’s Path LMS™ and included 21 professionally produced live stream sessions over three days. Using the dedicated, custom-branded Path LMS site, attendees could easily register and attend the live stream within the same platform allowing for a seamless learner experience.
Before the event, Blue Sky eLearn professionally recorded and edited the sessions, which played as “mock live” presentations. By pre-recording the sessions, there was a consistent look and feel, and the presenters were more comfortable knowing their sessions would be seamlessly broadcast without any technical failures, and they were able to focus on the live Q&A during the event.
The Global Cancer Drug Development Workshop was the third event managed by Blue Sky eLearn utilizing Path LMS. We were honored to lend our support through the Blue Skies Ahead Grant to this crucial virtual workshop. Our hope is that it serves as a shining example for future virtual events, allowing medical organizations to swiftly reach a broader audience and make a meaningful difference in combating both rare and common diseases in all corners of the world.
Explore what buyer personas are, why associations should use them, and learn the actionable steps to creating buyer personas tailored to your organization.
Blue Sky eLearn's Path LMS has been named a 2023 Top 40 Learning System and a Top 15 Specialty Learning System by Talented Learning.
The Freedom to Invest in Tomorrow’s Workforce Act aims expand 529 college savings plans to cover more workforce training and development costs. That means exciting possibilities for associations!
Path LMS is used by hundreds of organizations to deliver high-quality online learning, networking events, and conferences. Book a demo today!